New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareLiraglutide vs GHK

Liraglutide vs GHK

Side-by-side comparison of key properties, dosing, and research.

GLP-1 / Weight Loss AgonistsFat Loss & Metabolic
Liraglutide
Skin & CosmeticAnti-Aging & Longevity
GHK
Summary
Liraglutide is a long-acting GLP-1 receptor agonist approved for type 2 diabetes (Victoza) and chronic weight management (Saxenda). It reduces appetite, slows gastric emptying, improves insulin secretion, and promotes weight loss of 5–10% in clinical trials.
GHK is the natural tripeptide (Gly-His-Lys) released from human albumin that activates tissue remodeling, collagen synthesis, and anti-aging gene expression. The copper-free form is the biological signaling molecule; it chelates copper in tissue to form GHK-Cu but also has independent biological activity.
Half-Life
~13 hours (once-daily dosing)
Extremely short as free peptide; tissue binding extends local effects
Admin Route
SubQ
SubQ, Topical, Oral
Research
Typical Dose
Start 0.6 mg, titrate to 3 mg
100–500 mcg
Frequency
Once daily
Daily or 5x per week
Key Benefits
  • Promotes weight loss (5–10% average)
  • Reduces appetite and caloric intake
  • Improves blood glucose control (HbA1c reduction)
  • Reduces cardiovascular events in T2DM (LEADER trial)
  • Slows gastric emptying
  • FDA-approved for T2DM and chronic weight management
  • Cardioprotective effects shown in clinical trials
  • May improve fatty liver (NAFLD/NASH)
  • Stimulates collagen and extracellular matrix synthesis
  • Activates tissue repair gene expression programs
  • Anti-aging: reverses 57% of age-related gene changes
  • Antioxidant and anti-inflammatory
  • Wound healing and skin barrier repair
  • Improves skin laxity, texture, and radiance
  • Neuroprotective (stimulates NGF, BDNF)
  • Anti-fibrotic in liver and lung models
Side Effects
  • Nausea (very common, especially initially)
  • Vomiting
  • Diarrhea or constipation
  • Decreased appetite
  • +5 more
  • Excellent safety profile (naturally occurring peptide)
  • Rare: mild injection site reaction (SC)
  • No significant adverse effects identified in research
Stacks With